A multi-year pandemic has brought new challenges for biotech and pharma, but also plenty of triumphs and opportunities for innovation.
As we approach the upcoming J. P. Morgan Healthcare Conference, the unofficial kickoff to the year for the biopharma and healthcare community, it is time to discuss the year ahead. What does 2023 have in store for us and where will we go next?
I am pleased to announce that Fierce is back live in San Francisco, and we want you to come with us. Join us January 10th at the Fairmont San Francisco for a full day of content, networking and refreshments.
From the future of immuno-oncology to the state of the biotech capital markets, some of the greatest minds in biotech and pharma will take stock of current trends, discuss the important issues to watch in 2023 and share innovative strategies to thrive in the rapidly evolving space.
Space will be limited so don’t wait to register. Click here to reserve your seat today.
 | Rebecca Willumson |
